Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Riederer

Showing results (81-90 of 244) with videos related to

Pageof 25
Sort By:
Journal of Alzheimer'S Disease : JAD|August 8, 2009
Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-betaMelita Salkovic-Petrisic, Jelena Osmanovic, Edna Grünblatt, et al.
Journal of Neurochemistry|January 18, 2006
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathwayMelita Salkovic-Petrisic, Florian Tribl, Manuela Schmidt, et al.
Experimental Neurology|July 13, 2004
Perineuronal nets potentially protect against oxidative stressMarkus Morawski, Martina K Brückner, Peter Riederer, et al.
Advances in Experimental Medicine and Biology|June 23, 2004
Drosophila mutants of the kynurenine pathway as a model for ageing studiesElena V Savvateeva-Popova, Andrey V Popov, Thoralf Heinemann, et al.
Neuro-Degenerative Diseases|August 16, 2006
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screeningsEvelyn Braungart, Manfred Gerlach, Peter Riederer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2004
Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned ratManfred Gerlach, Maarten van den Buuse, Charles Blaha, et al.
Therapeutic Drug Monitoring|October 14, 2006
Pharmacokinetic characterization of amantadine in human brain tissueJohannes Kornhuber, Peter Riederer, Stefan Bleich, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampusDirk Moser, Anne Molitor, Robert Kumsta, et al.
Neuropsychobiology|August 20, 2005
Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patientsMartin Lauer, Silvia Johannes, Sabrina Fritzen, et al.
Therapeutic Drug Monitoring|December 25, 2013
The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysisStefan Unterecker, Florian Proft, Peter Riederer, et al.
Pageof 25

Showing results (81-90 of 244) with videos related to

Sort By:
Pageof 25
Journal of Alzheimer'S Disease : JAD|August 8, 2009
Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-betaMelita Salkovic-Petrisic, Jelena Osmanovic, Edna Grünblatt, et al.
Journal of Neurochemistry|January 18, 2006
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathwayMelita Salkovic-Petrisic, Florian Tribl, Manuela Schmidt, et al.
Experimental Neurology|July 13, 2004
Perineuronal nets potentially protect against oxidative stressMarkus Morawski, Martina K Brückner, Peter Riederer, et al.
Advances in Experimental Medicine and Biology|June 23, 2004
Drosophila mutants of the kynurenine pathway as a model for ageing studiesElena V Savvateeva-Popova, Andrey V Popov, Thoralf Heinemann, et al.
Neuro-Degenerative Diseases|August 16, 2006
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screeningsEvelyn Braungart, Manfred Gerlach, Peter Riederer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2004
Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned ratManfred Gerlach, Maarten van den Buuse, Charles Blaha, et al.
Therapeutic Drug Monitoring|October 14, 2006
Pharmacokinetic characterization of amantadine in human brain tissueJohannes Kornhuber, Peter Riederer, Stefan Bleich, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampusDirk Moser, Anne Molitor, Robert Kumsta, et al.
Neuropsychobiology|August 20, 2005
Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patientsMartin Lauer, Silvia Johannes, Sabrina Fritzen, et al.
Therapeutic Drug Monitoring|December 25, 2013
The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysisStefan Unterecker, Florian Proft, Peter Riederer, et al.
Pageof 25